vimarsana.com

Latest Breaking News On - Redhill biopharma - Page 1 : vimarsana.com

Crohn s Disease Market Is Predicted To Exhibit Remarkable Growth From (2024-2034), Analyzes Delveinsight

RedHill Biopharma (NASDAQ:RDHL) Now Covered by StockNews com

StockNews.com began coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research note issued to investors on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. RedHill Biopharma Stock Performance Shares of RedHill Biopharma stock opened at $0.46 on Tuesday. RedHill Biopharma has a twelve month low of $0.26 […]

RedHill Biopharma (NASDAQ:RDHL) Share Price Passes Below 200-Day Moving Average of $0 75

Shares of RedHill Biopharma Ltd. (NASDAQ:RDHL – Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.75 and traded as low as $0.46. RedHill Biopharma shares last traded at $0.46, with a volume of 107,800 shares traded. Analyst Upgrades and Downgrades Separately, […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.